Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. - Wikidata - wikimedia - TriplyDB

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

http://www.wikidata.org/entity/Q35111592

about

Rapid antidepressant effects: moving right along Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains Brain-derived neurotrophic factor: role in depression and suicide Neurobiology of depression: an integrated view of key findings Brain Structural Effects of Antidepressant Treatment in Major Depression Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date Signal transduction and genes-to-behaviors pathways in psychiatric diseases Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response New approaches to antidepressant drug discovery: beyond monoamines Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition Advances in the treatment of anxiety: targeting glutamate.How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.Stress sensitive female macaques have decreased fifth Ewing variant (Fev) and serotonin-related gene expression that is not reversed by citalopram.Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression.Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.Effect of ovarian hormones on genes promoting dendritic spines in laser-captured serotonin neurons from macaques Implications of adult hippocampal neurogenesis in antidepressant action.Efficacy and tolerability of agomelatine in the treatment of depression Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats.From synapse to nucleus: novel targets for treating depression.Physical Activity Modulates Common Neuroplasticity Substrates in Major Depressive and Bipolar Disorder.The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats.Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder GABAergic neurons in nucleus accumbens are correlated to resilience and vulnerability to chronic stress for major depression.Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care.A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.Antipsychotic-induced gene regulation in multiple brain regions.Mifepristone prevents stress-induced apoptosis in newborn neurons and increases AMPA receptor expression in the dentate gyrus of C57/BL6 mice Ovarian steroids increase glutamatergic related gene expression in serotonin neurons of macaques.Ovarian steroids increase spinogenetic proteins in the macaque dorsal raphe.Effect of ovarian steroids on gene expression related to synapse assembly in serotonin neurons of macaques.Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects Dendritic morphology of hippocampal and amygdalar neurons in adolescent mice is resilient to genetic differences in stress reactivity.The role of BDNF as a mediator of neuroplasticity in bipolar disorder.Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action.Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

P2860

Q24614410-0FCEBCCF-2CC6-4031-B515-6AD1C8A0B8EA Q24632901-0C1F745C-9D93-49EB-9DB3-224BB9A0C20A Q24647110-257461DB-4B89-4957-91F4-A9B22605820F Q24655216-30B1430C-B4E2-4AE1-8827-53709872DB86 Q26786239-89122A91-B963-4FCF-A3FA-DB6BC039E4AB Q27004490-47C5F856-B831-4B5A-BDCF-518C3AF22096 Q28182063-96664505-3B0F-4D70-B8C0-7DEE3C173AF1 Q28238686-8DE88E60-372B-4F17-812E-4174EC087C4F Q28252209-6312FE47-5B05-4EEC-9A7D-8D3A1BB0010B Q28293089-8B3F6369-F9DE-48D7-B3C9-6C996B98B628 Q28294148-726D6D4C-FC68-4080-BCC0-43A3D7A7F19F Q28468536-88218FE7-E0F0-464E-BFA2-FB49E47C0786 Q30457479-5E4DF3E2-A233-47F8-8CE5-7DBD94FC81D4 Q30485725-C3A34B73-04E6-4D75-A43E-331739D777EC Q30490951-4D6AE688-65C4-4673-984C-51A65718DE4D Q30491061-A0378E73-7BE5-41DD-A4ED-075EB21B93D9 Q31156853-99AE77D6-068B-4860-B215-2683854D80C1 Q33429548-B7A014F8-5C0D-426F-80A9-844E3D3BC23E Q33494309-E66314A9-F515-473E-852E-99EF609079AC Q33553686-0DCC720E-D4EE-4DC0-BEB9-3FCA7EEF722D Q33583450-BA059891-1D5A-4A47-8F41-EE3369C00103 Q33624583-EABCED2F-8372-4FF2-86EA-36603E69851A Q33653177-2A4071D9-BBC7-401C-82C1-8E8C41C71367 Q33655590-DD747AA3-795A-4F1E-A5A6-69EC2070F570 Q33712487-9A2B993A-8C17-47FD-B0E5-8656550CD935 Q33783427-4A471D1B-84BA-43AE-979D-DBC0AD91AAB2 Q33829363-544514B1-0805-493B-B468-B9A230687574 Q33835333-994B2E98-C4B1-4F88-BBBE-332F763913C0 Q33953387-4EF07A40-0489-4482-A8D3-90C4B3C1CD47 Q34066954-527E1106-E486-4840-ABEB-C768F628B423 Q34091504-65181E4A-770D-4C6E-A098-2A7060969697 Q34095573-06B38381-60A7-48EC-8F75-98CE21191E2D Q34161343-CD87A96C-B381-4E98-ACF2-0ECC3DC3E0AB Q34192562-56AC6502-4FD7-4634-B665-47D6ACC37978 Q34254887-A4409CEC-EF31-4D18-B467-EEC93E624F58 Q34305851-1EE6F06A-1741-4337-919E-DB02D16845D6 Q34497541-003A7A85-0DF4-4CA6-8E5A-1D3F37B770F6 Q34522617-9B89AE09-0764-495D-8C8F-5172EC0D394C Q34621808-D20C76DF-DC18-49E7-ACE4-E518C03EB783 Q34655680-1868C226-6D1B-4A3C-9957-8B59680E511C

P2860

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

http://www.wikidata.org/entity/Q35111592

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Enhancing neuronal plasticity ...... difficult-to-treat depression.

@ast

Enhancing neuronal plasticity ...... difficult-to-treat depression.

@en

type

label

Enhancing neuronal plasticity ...... difficult-to-treat depression.

@ast

Enhancing neuronal plasticity ...... difficult-to-treat depression.

@en

prefLabel

Enhancing neuronal plasticity ...... difficult-to-treat depression.

@ast

Enhancing neuronal plasticity ...... difficult-to-treat depression.

@en

P1433

Q35111592-393D232E-6070-49FC-955F-B7BC85C372A4

P1476

Q35111592-6DF180AC-2E16-4B1D-ADE0-E079FB81B37D

P2093

Q35111592-26E3BFF8-CC44-43F4-A748-C858B2D4A429

Q35111592-39983228-CBE0-4392-A646-C1703C567A3F

Q35111592-4FD01697-D95D-4AEA-A6C4-663FDF16FAB2

Q35111592-578BCA15-185F-4933-8747-D0C00FB91EAE

Q35111592-90013E4F-B0BF-4ECC-A591-F2D40493F98D

Q35111592-947FF532-363F-4DB2-A30A-4673E7B15496

Q35111592-E8467564-2CD2-4589-9C3C-BDF3CE4F5C3F

Q35111592-FA53F01A-2D71-4DA4-B8C7-AD78B2C5864D

P304

Q35111592-E14CA1F1-BAB3-475E-A7DA-AC047C309855

P31

Q35111592-72A3DFAF-3848-4416-AC4D-4FE0D88A3B09

P356

Q35111592-5EE2BE4B-6964-437A-AD6E-DE49A89C3E33

P407

Q35111592-D7C3FF42-FAB5-4D9A-B7AF-EE6522B3E02E

P433

Q35111592-9B4E0580-A873-4ECC-BB4A-9111AF7448F2

P478

Q35111592-8C886106-0F1D-467F-A68E-0BD6F666B599

P577

Q35111592-ABCF8C50-0D35-4F98-BA1C-EFD7B6598D7A

P698

Q35111592-505130DC-A86B-4E8B-B0E5-47B808DD6B0D

P356

S0006-3223(03)00117-3

P1433

Biological Psychiatry

P1476

Enhancing neuronal plasticity ...... difficult-to-treat depression.

@en

P2093

Carlos A Zarate

http://www.w3.org/2001/XMLSchema#string

Dennis S Charney

http://www.w3.org/2001/XMLSchema#string

Husseini K Manji

http://www.w3.org/2001/XMLSchema#string

Jennifer L Payne

http://www.w3.org/2001/XMLSchema#string

Jonathan Sporn

http://www.w3.org/2001/XMLSchema#string

Jorge A Quiroz

http://www.w3.org/2001/XMLSchema#string

Kirk Denicoff

http://www.w3.org/2001/XMLSchema#string

Neil A Gray

http://www.w3.org/2001/XMLSchema#string

P304

707-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0006-3223(03)00117-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12706957

http://www.w3.org/2001/XMLSchema#string